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INTRODUCTION
Paragonimiasis is a zoonotic disease caused by the trema­
tode Paragonimus spp. About 48 species of Paragonimus have 
been described; however, only 16 of these infect humans. Para-
gonimus wetermani is the most common species infecting hu­
mans, causing pulmonary and pleural inflammation through 
ingestion of raw freshwater crabs or crayfish infected with the 
metacercariae, the infective stage of this parasite [1]. However, 
patients diagnosed with paragonimiasis occasionally report 
that they had never eaten freshwater crabs or crayfish. There is 
a possibility that they ate food contaminated with metacercar­
iae from the fingers or cooking utensils of people who recently 
handled these crustaceans [2]. 
Patients with paragonimiasis reveal a wide variety of radio­
graphic and CT findings, including pulmonary nodules or ma­
sses, and sometimes they are suspected to have a lung tumor 
[3]. FDG (fluorodeoxyglucose)­PET (positron emission tomo­
graphy) is used recently to differentiate benign from malignant 
lesions, and it has been shown to be more effective than CT [4]. 
However, FDG is not a cancer­specific agent, and false positive 
findings in benign diseases, including paragonimiasis, have 
been reported [5­9]. Unlike those cases mimicking primary 
lung tumors, we report a case of pulmonary paragonimiasis 
with false­positive FDG­PET mimicking a metastatic lung tu­
mor. 
CASE REPORT
A 27­year­old woman was admitted to a local hospital with 
productive cough and blood­tinged sputum. Chest X­ray 
showed multiple nodules and she received anti­tuberculosis 
chemotherapy for 2 months. A follow­up chest X­ray taken 2 
months later revealed an increased size of the nodules, and the 
patient was referred to our hospital. She had no history of in­
gestion of freshwater crabs, crayfish, or wild pig meats. On ad­
mission, she was in good general health, and the physical ex­
amination was normal. A complete blood cell count (CBC) 
revealed WBC levels of 11,670/mm
3, hemoglobin levels of 
12.6 g/dL, platelet levels of 244,000/mm
3, absolute eosinophil 
count (AEC) of 6,185/mm
3. Serum tumor markers showed a 
high CA 125 level of 47.6 U/ml (normal <35 U/ml). Other 
laboratory tests revealed no abnormal findings. A chest X­ray 
showed multiple mass­like opacities in the right lung (Fig. 
1A). Chest CT revealed multiple nodules with adjacent areas 
of ground­glass opacity (GGO), which corresponded to hem­
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orrhagic infarcts as in a case of hemorrhagic metastasis or oth­
er benign conditions (Fig. 1B). FDG­PET CT was performed to 
find out a possible primary site of malignancy. However, it re­
vealed no remarkable abnormal finding except an increased 
FDG uptake (max SUV: 3.1) in the lung lesions (Fig. 2). Bron­
choscopic and cytological examination of the sputum showed 
nothing of particular significance. We could not observe para­
site eggs in stool, sputum, or bronchoalvelolar lavage (BAL) 
fluid. However, ELISA (Genedia Ab ELISA, Green Cross MS, 
Yongin, Korea) was positive for antibodies against P. wester-
mani. She received praziquantel therapy (25 mg/kg, 3 times a 
day for 2 days). At a week after the medication, the patient’s 
eosinophil count decreased from 6,185/mm
3 to 2,468/mm
3. 
A follow­up chest X­ray at 4 months after the treatment showed 
interval decrease in the size of multiple nodules in the right 
lung and CT at 6 months after the treatment revealed marked­
ly diminished nodules in size with cystic changes (Fig. 3). 
DISCUSSION
Paragonimiasis is a food­borne parasitic disease caused by 
the trematode P. wertermani, which is endemic in East Asia [1]. 
Adult P. westermani worms are bean­shaped, 5­12 mm long, 
3­6 mm wide, and 2­5 mm thick, a size that can be seen on ra­
diologic images. Several studies reported that the common ra­
diologic findings of pleuropulmonary paragonimiasis includ­
ed pleural effusion, hydropneumothorax, pulmonary nodules, 
or air­space consolidation, and cysts [10]. A report by Kim et 
al. [11] suggested that the main CT feature of pleuropulmo­
nary paragonimiasis in 31 patients was pulmonary nodules, 
including multiple nodules in 7 patients (23%) as in our pa­
tient. In the present case, areas of surrounding GGO were ob­
served around the nodules, which suggest hemorrhage. It led 
us to consider the findings as hemorrhagic metastasis, though 
these finding are also shown in a number of benign conditions, 
such as angioinvasive aspergillosis and paragonimiasis [12]. 
Abnormally increased FDG uptake (max SUV: 3.1) in the lung 
lesions on FDG­PET CT supported a possibility of malignancy 
further. 
FDG­PFT is a highly accurate imaging in evaluating pulmo­
nary lesions, taking advantage of the higher metabolic rate of 
tumor cells to show increased accumulation of FDG in malig­
nant lesions. However, an increased metabolic rate is also ob­
B
Fig. 1. Chest X-ray and computed tomography (CT) on admission. 
(A) Multiple mass-like opacities are shown in the right lung (arrow). 
(B) Multiple nodules with adjacent areas of GGO, suggestive of he-
morrhagic metastasis are observed in both lungs (arrows).
A
Fig. 2. FDG-PET CT showed increased FDG uptake (max SUV: 
3.1) (arrows).  Kim et al.: Pulmonary paragonimiasis mimicking metastatic tumor   71
served in inflammation [13,14]. Many reports have demon­
strated increased FDG uptake in inflammatory, granulomatous, 
and infectious lung diseases, including bacterial, mycobacteri­
al, fungal, and parasitic infections. 
Several cases of pulmonary paragonimiasis were reported 
that showed a high uptake suggestive of a malignancy on FDG­
PET CT images [5­9]. All of them were suspected as primary 
lung cancers and confirmed as paragonimiasis by detecting 
eggs in the tissue obtained from biopsy or operation. Although 
the definite causes of FDG accumulation have not yet been 
proven in paragonimiasis, it seems likely that inflammatory 
cells, including eosinophilic infiltration, active inflammatory 
responses, and viable worms, cause a high FDG uptake [4].
The diagnosis of paragonimiasis can be made by detecting 
eggs in the tissue section, or more commonly, in the stool, spu­
tum, or BAL fluid, or by a positive anti­Paragonimus antibody 
test. However, egg detection rates have been reported to be low 
(28­38%) and eggs are not present in the sputum until 2­3 
months after an infection. Serum determination of antibodies 
to Paragonimus is more accurate in early infections, and ELISA 
is highly sensitive (92%) and specific [15]. In our case, Para-
gonimus eggs were not found in the stool, sputum, and BAL 
fluid. Instead, the patient’s serum strongly reacted to P. werter-
mani antigen in ELISA. 
Considering lung nodular lesions with GGO on chest X­ray 
and CT, in combination with ELISA test for paragonimiasis, 
FDG­PET itself was an unnecessary examination to diagnose 
paragonimiasis in our patient. In addition, nodular lesions 
were continuing to the visceral pleura, which is rather unusual 
for metastatic lung cancers. On the other hand, Paragonimus 
invades from the pleural cavity to the lung parenchyma so that 
continuous lesions from the pleura to the nodular lesion in 
the lung parenchyma are a typical feature of radiological find­
ing in paragonimiasis. Nevertheless, FDG­PET was performed 
to exclude the possibility of malignancy owing to the elevated 
serum level of CA 125. The serum CA 125 is often increased in 
patients with malignancy, such as ovarian cancer, endometrial 
cancer, and pancreatic cancer. However, it is also increased in a 
variety of benign conditions, including endometriosis, uterine 
fibroids, pelvic inflammatory disease, heart failure, liver and 
renal disease, as well as in approximately 1 percent of healthy 
women [16]. There has been no report of paragonimiasis pa­
tients showing high level of CA 125.
As a possibility in the differential diagnosis of multiple pul­
monary nodules or masses with FDG­PET positive finding, es­
pecially in endemic regions with a high prevalence of food­
borne parasitic diseases, paragonimiasis should be considered. 
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